Prelude Therapeutics (PRLD) Leases (2024 - 2025)
Historic Leases for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to $27.5 million.
- Prelude Therapeutics' Leases fell 559.59% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 559.59%. This contributed to the annual value of $28.7 million for FY2024, which is N/A changed from last year.
- Per Prelude Therapeutics' latest filing, its Leases stood at $27.5 million for Q3 2025, which was down 559.59% from $27.9 million recorded in Q2 2025.
- Prelude Therapeutics' 5-year Leases high stood at $30.1 million for Q1 2024, and its period low was $27.5 million during Q3 2025.